Friday 6 November 2026
Export DD’s income statement to Excel — free account
DuPont de Nemours, Inc.
DD Basic Materials Specialty Chemicals
DuPont de Nemours, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.8 billion, up 1.93% from fiscal 2024.
- Revenue
- +4.07%
- EPS
- +207.8%
- Free cash flow
- +36.7%
- Total debt
- −65.2%
Quarter to September 2026, against a year earlier
145.08
5.65
−3.75%
Follow DD
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Sep ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | 48,158 | 11,672 | 22,594 | 15,436 | 11,128 | 12,566 | 13,017 | 6,614 | 6,719 | 6,849 | 7,061 | (19.5%) | 7,165 | 7,450 | 7,758 | +4.2% | |
| Gross margin, % | 21.78 | 18.11 | 32.27 | 35.05 | 36.53 | 36.57 | 35.45 | 32.84 | 33.04 | 34.50 | 35.49 | +12.7 pt | ||||||
| EBT | 4,413 | (1,525) | 600 | (126) | (1,259) | 1,444 | 1,448 | (279) | 117 | 200 | 660 | (29.1%) | ||||||
| EBT margin, % | 9.16 | (13.07) | 2.66 | (0.82) | (11.31) | 11.49 | 11.12 | (4.22) | 1.74 | 2.92 | 9.35 | (6.2) pt | ||||||
| Net income | 4,404 | 1,291 | 4,000 | 600 | (2,923) | 6,515 | 5,917 | 462 | 738 | (738) | 317 | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | 391.22 | 66.50 | 88.38 | 62.06 | 45.39 | 69.47 | 78.34 | 44.11 | 48.09 | 49.22 | 52.58 | (20.6%) | |||||
| Earnings | 32.14 | 6.53 | 14.94 | 2.01 | (12.03) | 35.76 | 34.89 | 2.82 | 5.04 | (5.61) | 2.26 | n/m | ||||||
| Cash flow | (24.02) | (4.36) | 18.51 | 5.66 | 16.70 | 10.21 | 7.52 | 5.64 | 5.48 | 4.02 | 8.41 | n/m | ||||||
| Capex | (29.51) | (5.24) | (14.65) | (8.74) | (0.66) | 0.05 | 61.93 | 6.23 | (2.09) | (2.39) | (2.50) | (24.4%) | ||||||
| Free cash flow | (53.53) | (9.59) | 3.86 | (3.07) | 16.05 | 10.26 | 69.44 | 11.86 | 3.39 | 1.63 | 5.90 | n/m | ||||||
| Book value | 221.20 | 580.73 | 375.14 | 167.06 | 159.38 | 149.55 | 162.61 | 164.89 | 170.29 | 101.35 | 101.94 | (8.3%) | ||||||
| Shares, m | 123 | 176 | 256 | 249 | 245 | 181 | 166 | 150 | 140 | 139 | 137 | +1.4% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | 3.22 | 12.44 | 8.92 | 39.53 | 0.00 | 3.04 | 2.38 | 34.39 | 18.62 | 0.00 | 64.25 | 12.3 | |||||
| P/S | 0.26 | 2.69 | 1.51 | 1.28 | 1.94 | 1.44 | 1.09 | 1.19 | 1.96 | 2.45 | 2.76 | 1.6 | ||||||
| P/B | 0.47 | 0.31 | 0.36 | 0.48 | 0.55 | 0.67 | 0.52 | 0.58 | 0.55 | 1.19 | 1.42 | 0.6 | ||||||
| EV/Sales | 0.56 | 4.21 | 1.69 | 2.31 | 3.11 | 2.14 | 1.33 | 1.65 | 2.76 | 2.81 | 2.97 | 2.3 | ||||||
| EV/FCF | (4.12) | (29.20) | 38.68 | (46.69) | 8.81 | 14.50 | 1.50 | 11.16 | 39.24 | 84.66 | 26.43 | 11.9 | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | (2,957) | (765) | 4,731 | 1,409 | 4,095 | 1,846 | 1,249 | 845 | 765 | 560 | 1,129 | n/m | |||||
| Capex | (3,633) | (919) | (3,745) | (2,173) | (161) | 9 | 10,289 | 934 | (292) | (333) | (336) | (23.3%) | ||||||
| Free cash flow | (6,590) | (1,684) | 986 | (764) | 3,934 | 1,855 | 11,538 | 1,779 | 473 | 227 | 793 | n/m | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | 11,055 | 23,765 | 53,343 | 1,653 | 16,782 | 9,372 | 7,537 | 4,416 | 15,279 | 3,270 | 2,730 | (12.7%) | |||||
| Net debt | 14,484 | 17,729 | 4,062 | 15,907 | 13,068 | 8,810 | 3,103 | 4,997 | 5,373 | 2,437 | 1,435 | (18.0%) | ||||||
| Shareholders’ equity | 27,229 | 101,927 | 95,900 | 41,556 | 39,070 | 27,050 | 27,017 | 24,725 | 23,793 | 14,103 | 13,690 | (7.0%) | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | 5.40 | 0.85 | 2.02 | 0.39 | (4.21) | 11.09 | 13.48 | 1.06 | 1.87 | (2.68) | 1.02 | (8.1) pt | |||||
| ROIC | 7.24 | (0.99) | 0.13 | 0.50 | (0.91) | 3.28 | 3.87 | 0.24 | 1.05 | 1.96 | 3.43 | (5.3) pt | ||||||
| ROE | 16.10 | 1.79 | 3.89 | 0.72 | (7.32) | 19.56 | 21.71 | 1.64 | 2.90 | (4.11) | 1.63 | (20.2) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | 56,000 | 98,000 | 98,000 | 35,000 | 34,000 | 28,000 | 23,000 | 24,000 | 24,000 | 15,000 | — | (13.6%) | |||||
| Revenue/emp, $m | 0.86 | 0.12 | 0.23 | 0.44 | 0.33 | 0.45 | 0.57 | 0.28 | 0.28 | 0.46 | — | (6.8%) | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026
Business profile
DuPont de Nemours, Inc. vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| PPG PPG Industries, Inc. | $27.2B | 17.6× | 16.2× | +6.64% (above 0%: growing) | +1.00% (above 0%: growing) | −23.61% (below 0%: shrinking) | 40.52% | 14.89% | Compare |
| IFF International Flavors & Fragrances Inc. | $21.6B | 121× | 60.3× | +3.91% (above 0%: growing) | n/m | −123.33% (below 0%: shrinking) | 42.48% | 8.24% | Compare |
| LYB LyondellBasell Industries N.V. | $19.9B | 15.6× | 9.2× | +9.99% (above 0%: growing) | n/m | +144.89% (above 0%: growing) | 17.60% | 12.55% | Compare |
| DD DuPont de Nemours, Inc. | $19.2B | 64.2× | 26.3× | +4.07% (above 0%: growing) | n/m | +36.69% (above 0%: growing) | 35.71% | 16.81% | |
| RPM RPM International Inc. | $13.5B | 19.5× | 17.3× | +4.82% (above 0%: growing) | +13.48% (above 0%: growing) | +33.14% (above 0%: growing) | 41.25% | 15.99% | Compare |
| ALB Albemarle Corporation | $11.6B | 22.6× | 9.9× | +18.75% (above 0%: growing) | n/m | +708.43% (above 0%: growing) | 19.36% | 9.54% | Compare |
| SSL Sasol Ltd. | $9.6B | 3.3× | 5.5× | −5.20% (below 0%: shrinking) | +20.86% (above 0%: growing) | +6,912.65% (above 0%: growing) | 31.35% | 0.00% | Compare |
| SOLS Solstice Advanced Materials Inc. | $8.8B | 26.5× | 20.5× | +7.95% (above 0%: growing) | −11.11% (below 0%: shrinking) | +276.34% (above 0%: growing) | 32.98% | 15.68% | Compare |
| WLK Westlake Corporation | $8.5B | — (loss-making) | 36.7× | +5.04% (above 0%: growing) | n/m | +485.96% (above 0%: growing) | 12.81% | 1.44% | Compare |
| Median of peers | $12.5B | 19.5× | 16.8× | +5.84% | +7.24% | +210.62% | 32.17% | 11.04% |
Largest institutional holders 13F, quarter to 30 June 2026
| Holder | Shares | Stake | Change |
|---|---|---|---|
| Vanguard | 16.82m | — | +16.82m |
| BlackRock | 10.64m | — | +10.64m |
| Invesco | 3.79m | — | +3.79m |
| Geode Capital Management | 3.75m | — | +3.75m |
| Morgan Stanley | 2.72m | — | +2.72m |
| Victory Capital | 2.35m | — | +2.35m |
| Goldman Sachs | 2.05m | — | +2.05m |
| UBS | 2.02m | — | +2.02m |
| Northern Trust | 1.60m | — | +1.60m |
| JPMorgan Chase | 1.52m | — | +1.52m |
13F filings for the quarter to 30 June 2026: long positions in US-listed shares reported by managers with $100m or more, ~45 days after the quarter.
DuPont de Nemours, Inc. (DD) Latest News
3 Nov
28 Oct
24 Oct
23 Oct
6 Oct
30 Sep
DD metrics, ten years each
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
DuPont de Nemours sells materials, components and technologies used in healthcare, water treatment, construction and industrial manufacturing. Founded in 2015 and headquartered in Wilmington, the company is led by Chief Executive Officer Lori Koch.
Its Healthcare & Water Technologies segment supplies medical packaging, protective garments and components for medical devices, as well as technologies that filter and purify water. Its customers use these products in applications ranging from packaging medical equipment to treating industrial wastewater and producing drinking water.